Concord Drugs consolidated net profit rises 1225.00% in the March 2026 quarter

Sales rise 264.68% to Rs 37.89 crore

Net profit of Concord Drugs rose 1225.00% to Rs 0.53 crore in the quarter ended March 2026 as against Rs 0.04 crore during the previous quarter ended March 2025. Sales rose 264.68% to Rs 37.89 crore in the quarter ended March 2026 as against Rs 10.39 crore during the previous quarter ended March 2025.

For the full year,net profit rose 211.76% to Rs 1.06 crore in the year ended March 2026 as against Rs 0.34 crore during the previous year ended March 2025. Sales rose 74.05% to Rs 78.74 crore in the year ended March 2026 as against Rs 45.24 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	37.89	10.39	265	78.74	45.24	74
OPM %	3.96	10.11	-	5.78	9.17	-
PBDT	1.10	0.44	150	2.84	2.12	34
PBT	0.75	0.06	1150	1.47	0.69	113
NP	0.53	0.04	1225	1.06	0.34	212

Powered by Capital Market - Live News